News Center
News Center
News Center
-
- E6201, a MEK inhibitor with high blood-brain barrier penetration, is approved to
- 2020-08-10
-
- JS InnoPharm Announces First Patient Dosed with JSI-1187.
- 2020-07-10
-
- VITRAC Initiated Global Clinical Development of VIC-1911.
- 2020-06-29
-
- JS InnoPharm announced the completion of round a + financing, accelerating the r
- 2020-06-15
